Happiness Biotech Group (NASDAQ:HAPP) Coverage Initiated at Aegis

Stock analysts at Aegis started coverage on shares of Happiness Biotech Group (NASDAQ:HAPP) in a research report issued on Friday, The Fly reports. The firm set a “buy” rating on the stock.

HAPP traded up $0.07 on Friday, reaching $4.88. The company had a trading volume of 206 shares, compared to its average volume of 35,554. Happiness Biotech Group has a 52-week low of $3.91 and a 52-week high of $5.24.

About Happiness Biotech Group

Happiness Biotech Group Limited engages in the research, development, manufacture, and sale of nutraceutical and dietary supplements products made of Lucidum spore powder and others in the People's Republic of China. It also offers edible fungi. The company was founded in 2004 and is based in Nanping, the People's Republic of China.

Recommended Story: How Investors Use a Balance Sheet

The Fly

Receive News & Ratings for Happiness Biotech Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Happiness Biotech Group and related companies with MarketBeat.com's FREE daily email newsletter.